Three-dimensional quantitative T1 and T2 mapping of the carotid artery: Sequence design and in vivo feasibility
BF Coolen (Amsterdam UMC, External organisation)
DHJ Poot (TU Delft - ImPhys/Computational Imaging, Erasmus MC)
MI Liem (Amsterdam UMC, External organisation)
LP Smits (Amsterdam UMC, External organisation)
S Gao (Leiden University Medical Center, External organisation)
G Kotek (External organisation, Erasmus MC)
S Klein (External organisation, Erasmus MC)
AJ Nederveen (External organisation, Amsterdam UMC)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
Purpose
A novel three-dimensional (3D) T1 and T2 mapping protocol for the carotid artery is presented.
Methods
A 3D black-blood imaging sequence was adapted allowing carotid T1 and T2 mapping using multiple flip angles and echo time (TE) preparation times. B1 mapping was performed to correct for spatially varying deviations from the nominal flip angle. The protocol was optimized using simulations and phantom experiments. In vivo scans were performed on six healthy volunteers in two sessions, and in a patient with advanced atherosclerosis. Compensation for patient motion was achieved by 3D registration of the inter/intrasession scans. Subsequently, T1 and T2 maps were obtained by maximum likelihood estimation.
Results
Simulations and phantom experiments showed that the bias in T1 and T2 estimation was < 10% within the range of physiological values. In vivo T1 and T2 values for carotid vessel wall were 844 ± 96 and 39 ± 5 ms, with good repeatability across scans. Patient data revealed altered T1 and T2 values in regions of atherosclerotic plaque.
Conclusion
The 3D T1 and T2 mapping of the carotid artery is feasible using variable flip angle and variable TE preparation acquisitions. We foresee application of this technique for plaque characterization and monitoring plaque progression in atherosclerotic patients. Magn Reson Med 75:1008–1017, 2016.